SIGHT SCIENCES INC (SGHT) Stock Price, Quote, News and Overview
NASDAQ:SGHT - Nasdaq - US82657M1053 - Common Stock - Currency: USD
SGHT Quote, Performance and Key Statistics
SIGHT SCIENCES INC
NASDAQ:SGHT (1/24/2025, 4:30:02 PM)
After market: 2.93 0 (0%)2.93
-0.03 (-1.01%)
The current stock price of SGHT is 2.93 USD. In the past month the price decreased by -16.52%. In the past year, price decreased by -35.75%.
SGHT Latest News, Press Releases and Analysis
Sight Sciences Announces the Results of a Budget Impact Analysis for its TearCare® System for the Treatment of Meibomian Gland Disease (“MGD”) Showing Cost Savings Over Existing Reimbursed Treatment Options
Budget impact analysis published in the Expert Review of Ophthalmology journal...
Friday 11/22 Insider Buying Report: SGHT, WOLF
Sight Sciences to Present at the Piper Sandler 36th Annual Healthcare Conference
MENLO PARK, Calif., Nov. 19, 2024 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT) (
Sight Sciences is Now Oversold (SGHT)
SGHT Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 26.77 | 216.86B | ||
| ISRG | INTUITIVE SURGICAL INC | 79.68 | 208.03B | ||
| SYK | STRYKER CORP | 33.88 | 150.32B | ||
| BSX | BOSTON SCIENTIFIC CORP | 43.19 | 150.24B | ||
| MDT | MEDTRONIC PLC | 17.18 | 115.65B | ||
| BDX | BECTON DICKINSON AND CO | 18.5 | 70.60B | ||
| EW | EDWARDS LIFESCIENCES CORP | 25.84 | 40.69B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 21.01 | 40.51B | ||
| RMD | RESMED INC | 30.22 | 36.77B | ||
| IDXX | IDEXX LABORATORIES INC | 39.76 | 35.64B | ||
| DXCM | DEXCOM INC | 52.21 | 34.67B | ||
| PHG | KONINKLIJKE PHILIPS NVR- NY | 20.05 | 25.26B |
Related stock screener links
About SGHT
Company Profile
Sight Sciences, Inc. is an ophthalmic medical device company, which focuses on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. The company is headquartered in Menlo Park, California and currently employs 214 full-time employees. The company went IPO on 2021-07-15. The firm is focused on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. The firm operates through two segments: Surgical Glaucoma and Dry Eye. The product portfolio for the Surgical Glaucoma segment features the OMNI Surgical System, which is an implant-free glaucoma surgery technology indicated to reduce intraocular pressure in adult patients with primary open-angle glaucoma and the SION Surgical Instrument, a manually operated device used in ophthalmic surgical procedures to excise trabecular meshwork. The product portfolio for the Dry Eye segment consists of the TearCare System (TearCare) for ophthalmologists and optometrists. TearCare is a wearable eyelid technology that delivers targeted and adjustable heat to the meibomian glands of the eyelids in adult patients with evaporative dry eye disease due to meibomian gland disfunction.
Company Info
SIGHT SCIENCES INC
4040 Campbell Ave,, Suite 100
Menlo Park CALIFORNIA US
CEO: Paul Badawi
Employees: 214
Company Website: https://www.sightsciences.com/
Investor Relations: https://investors.sightsciences.com/
Phone: 14158890550
SGHT FAQ
What is the stock price of SGHT?
The current stock price of SGHT is 2.93 USD.
What is the symbol for SIGHT SCIENCES INC stock?
The exchange symbol of SIGHT SCIENCES INC is SGHT and it is listed on the Nasdaq exchange.
On which exchange is SGHT stock listed?
SGHT stock is listed on the Nasdaq exchange.
Is SGHT a good stock to buy?
Always make your own analysis. On these pages you can find a full technical and fundamental analysis report for SGHT, which may be a starting point for your analysis. You can also find the financials, news, analyst ratings and estimates here, which can be used to increase your understanding of SGHT.
Does SGHT stock pay dividends?
SGHT does not pay a dividend.
What is the Price/Earnings (PE) ratio of SGHT?
SGHT does not have a PE ratio as the earnings reported over the last twelve months were negative (-1.02).
What is the Short Interest ratio of SGHT stock?
The outstanding short interest for SGHT is 2.7% of its float.
SGHT Technical Analysis
SGHT Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to SGHT. The financial health of SGHT is average, but there are quite some concerns on its profitability.
SGHT Financial Highlights
Over the last trailing twelve months SGHT reported a non-GAAP Earnings per Share(EPS) of -1.02. The EPS decreased by 19.69% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -35.06% | ||
| ROE | -53.03% | ||
| Debt/Equity | 0.36 |
SGHT Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 74% to SGHT. The Buy consensus is the average rating of analysts ratings from 14 analysts.
For the next year, analysts expect an EPS growth of 9.16% and a revenue growth 0.01% for SGHT